COMPARATIVE ANALYSIS OF THE RESULTS OF USING PEPTIDES AND CITICOLINE AT DIFFERENT STAGES OF RETINITIS PIGMENTOSA-Reference-Cited by-同舟云学术

COMPARATIVE ANALYSIS OF THE RESULTS OF USING PEPTIDES AND CITICOLINE AT DIFFERENT STAGES OF RETINITIS PIGMENTOSA

Published:2024 Issue:88 Volume:20 Page:94
ISSN:2079-8334
Container-title:World of Medicine and Biology
language:en
Short-container-title:WOMAB

Author:

Mammadzada A. N.¹,Kasimov E. M.¹,Aliyeva N. I.¹,Orujova S. N.¹

Affiliation:

1. National Center of Ophthalmology named after Academician Zarifa Aliyeva

Publisher

Scientific Society Anatomists, Histologists, and Embryologists, Ukraine

Reference12 articles.

1. Savustyanenko AV. Tsitikolin: mekhanizm deystviya I klinicheskaya effektivnost' pri lechenii ishemicheskogo insul'ta, khronicheskikh tserebrovaskulyarnykh rasstroystv I travmaticheskogo povrezhdeniya golovnogo mozga. Mezhdunarodnyy Nevrologicheskiy Zhurnal. 2014: 2 (64): 115–120 [in Ukrainian].

2. Bhardwaj A, Yadav A, Yadav M, Tanwar M. Genetic dissection of non-syndromic retinitis pigmentosa. Indian Journal of Ophthalmology. 2022; 70(7):2355–2385. doi: 10.4103/ijo.ijo_46_22.3. Blaverez-Sabhn J, Romon GC. The role of citicoline in neuroprotection and neurorepair in ischemic stroke. Brain Sci., 2013, v.3, pp. 1395-1414.

3. Bruninx R, Lepièce G. L’image du mois. La rétinitepigmentaire [Retinitis pigmentosa]. Rev Med Liege. 2020 Feb;75(2):73–74. PMID: 32030928. [in French].

4. Domènech BE, Marfany G. The relevance of oxidative stress in the pathogenesis and therapy of retinal dystrophies. Antioxidants, 2020, 9, 347. https://doi.org/10.3390/antiox9040347.

5. Gashimova NF, Mamedova TM, Nasrullayeva MM, Babayeva LA, Mamedzadeh AN. Results of Retinalamin use in retinal dystrophies in children against the background of biostimulation. Ophthalmology, Baku, 2011/3 (7): 26–29.